Motivation: Spatial transcriptomics (ST) technologies provide richer insights into the molecular characteristics of cells by simultaneously measuring gene expression profiles and their relative locations. However, each slice can only contain limited biological variation, and since there are almost always non-negligible batch effects across different slices, integrating numerous slices to account for batch effects and locations is not straightforward. Performing multi-slice integration, dimensionality reduction, and other downstream analyses separately often results in suboptimal embeddings for technical artifacts and biological variations. Joint modeling integrating these steps can enhance our understanding of the complex interplay between technical artifacts and biological signals, leading to more accurate and insightful results.
Results: In this context, we propose a hierarchical hidden Markov random field model STADIA to reduce batch effects, extract common biological patterns across multiple ST slices, and simultaneously identify spatial domains. We demonstrate the effectiveness of STADIA using five datasets from different species (human and mouse), various organs (brain, skin, and liver), and diverse platforms (10x Visium, ST, and Slice-seqV2). STADIA can capture common tissue structures across multiple slices and preserve slice-specific biological signals. In addition, STADIA outperforms the other three competing methods (PRECAST, fastMNN, and Harmony) in terms of the balance between batch mixing and spatial domain identification, and it demonstrates the advantage of joint modeling when compared to STAGATE and GraphST.
Availability And Implementation: The source code implemented by R is available at https://github.com/zhanglabtools/STADIA and archived with version 1.01 on Zenodo https://zenodo.org/records/13637744.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512591 | PMC |
http://dx.doi.org/10.1093/bioinformatics/btae611 | DOI Listing |
Access Microbiol
January 2025
Department of Medical Laboratory Science, Faculty of Medical and Health Sciences, Liwa College, Abu Dhabi, UAE.
Proper identification and management of post-kala-azar dermal leishmaniasis (PKDL) and canine leishmaniasis (CanL) cases are among the prerequisites to the effective control of visceral leishmaniasis worldwide. Unlike PKDL, CanL still awaits effective improvement because of its cryptic nature, absence of parasites in lesions or lymph nodes and not complete sensitivity of some diagnostic tools in use. Because of the need for certain skills and equipment, both the liquid direct agglutination test and freeze-dried direct agglutination test (FD-DAT) versions are, in comparison with the indirect immunofluorescence antibody test (IFAT) or enzyme-linked immunosorbent assay (ELISA), practical and feasible diagnostic alternatives.
View Article and Find Full Text PDFJ Vet Res
December 2024
Department of Omics Analysis, National Veterinary Research Institute, 24-100 Puławy, Poland.
Introduction: In Europe, veterinary vaccines are strictly controlled by the Official Medicines Control Laboratories (OMCLs) of the General European OMCL Network, coordinated by the European Directorate for the Quality of Medicines & HealthCare. Despite a meticulous verification programme for immunological veterinary medicinal products (IVMPs), the products' genomic composition has not yet been subject to evaluation in veterinary pharmacy.
Material And Methods: A study was carried out on Poland's poultry vaccines containing the infectious bronchitis virus which have the greatest market penetration.
J Extracell Vesicles
January 2025
Cell-Tech HUB and Institute for Research and Biomedical Innovation (IRIB), National Research Council of Italy (CNR), Palermo, Italy.
The application of extracellular vesicles (EVs) as therapeutics or nanocarriers in cell-free therapies necessitates meticulous evaluations of different features, including their identity, bioactivity, batch-to-batch reproducibility, and stability. Given the inherent heterogeneity in EV preparations, this assessment demands sensitive functional assays to provide key quality control metrics, complementing established methods to ensure that EV preparations meet the required functionality and quality standards. Here, we introduce the detectEV assay, an enzymatic-based approach for assessing EV luminal cargo bioactivity and membrane integrity.
View Article and Find Full Text PDFDiscov Nano
January 2025
Particle Engineering Centre, Department of Chemical Engineering, Norwegian University of Science and Technology, Trondheim, 7491, Norway.
The increasing demand for magnetic iron oxide nanoparticles (IONPs) in biomedicine necessitates efficient and scalable production methods. Thermal decomposition offers excellent tailoring of the particle properties but its discontinuous batch-operation is restricting scale-up and industrial application. To overcome these challenges, several studies have demonstrated semi-continuous thermal decomposition by slowly injecting the precursor, though only half of them produce magnetite IONPs and even fewer use iron oleate precursors.
View Article and Find Full Text PDFBMC Cancer
January 2025
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Background: While immune checkpoint inhibitor (ICI) therapies can significantly improve outcomes for patients with recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC), only about 15-20% benefit from such treatments. Clinical tests that guide the use of ICIs are therefore critically needed. OncoPrism-HNSCC was developed to address this need.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!